A detailed history of Aqr Capital Management LLC transactions in Glaukos Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 6,529 shares of GKOS stock, worth $987,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,529
Previous 4,141 57.67%
Holding current value
$987,315
Previous $490,000 73.47%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$113.62 - $135.39 $271,324 - $323,311
2,388 Added 57.67%
6,529 $850,000
Q2 2024

Aug 14, 2024

BUY
$89.48 - $118.35 $18,880 - $24,971
211 Added 5.37%
4,141 $490,000
Q1 2024

May 15, 2024

BUY
$76.4 - $96.33 $51,340 - $64,733
672 Added 20.63%
3,930 $370,000
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $193,948 - $277,288
3,258 New
3,258 $258,000
Q2 2022

Aug 15, 2022

SELL
$34.86 - $63.77 $384,819 - $703,957
-11,039 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$44.33 - $57.82 $610,113 - $795,776
-13,763 Reduced 55.49%
11,039 $638,000
Q4 2021

Feb 14, 2022

BUY
$40.27 - $56.99 $326,589 - $462,188
8,110 Added 48.59%
24,802 $1.1 Million
Q3 2021

Nov 15, 2021

BUY
$47.43 - $84.23 $791,701 - $1.41 Million
16,692 New
16,692 $804,000
Q4 2019

Feb 14, 2020

SELL
$54.18 - $65.64 $607,737 - $736,283
-11,217 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$58.58 - $83.91 $1.58 Million - $2.26 Million
-26,986 Reduced 70.64%
11,217 $701,000
Q2 2019

Aug 14, 2019

BUY
$63.59 - $78.71 $1.62 Million - $2 Million
25,449 Added 199.54%
38,203 $2.88 Million
Q1 2019

May 14, 2019

SELL
$50.75 - $80.54 $24,157 - $38,337
-476 Reduced 3.6%
12,754 $1 Million
Q4 2018

Feb 14, 2019

BUY
$52.18 - $67.93 $690,341 - $898,713
13,230 New
13,230 $743,000
Q1 2018

May 15, 2018

SELL
$26.05 - $34.5 $594,096 - $786,807
-22,806 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$24.5 - $36.01 $558,747 - $821,244
22,806
22,806 $585,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.2B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.